GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Baolingbao Biology Co Ltd (SZSE:002286) » Definitions » Asset Impairment Charge

Baolingbao Biology Co (SZSE:002286) Asset Impairment Charge : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Baolingbao Biology Co Asset Impairment Charge?

Baolingbao Biology Co's Asset Impairment Charge for the three months ended in Mar. 2024 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.


Baolingbao Biology Co Asset Impairment Charge Historical Data

The historical data trend for Baolingbao Biology Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baolingbao Biology Co Asset Impairment Charge Chart

Baolingbao Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Baolingbao Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Baolingbao Biology Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


Baolingbao Biology Co Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Baolingbao Biology Co's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Baolingbao Biology Co (SZSE:002286) Business Description

Traded in Other Exchanges
N/A
Address
NO.1,Dongwaihuan Road, Hi-Tech Development Zone, Yucheng, CHN
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.
Executives
Zhang Guo Gang Directors, executives
Wang Qiang Directors, executives
Huang Yong Qiang Independent director
Jia Wei Chen Supervisors
Zhang Xin Rong Independent director
Liu Zong Li Directors, executives
Liu Feng Directors, executives
Li Xia Directors, executives
Wang Nai Qiang Supervisors
Xue Jian Ping Directors, executives
Yang Yuan Zhi Directors, executives

Baolingbao Biology Co (SZSE:002286) Headlines

No Headlines